Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

We conducted a phase II study of the combination of temozolomide and angiogenesis inhibitors for treating adult patients with newly diagnosed glioblastoma. Patients who had stable disease following standard radiation therapy received temozolomide for 5 days in 28-day cycles, in combination with dail...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kesari, Santosh, Schiff, David, Henson, John W., Muzikansky, Alona, Gigas, Debra C., Doherty, Lisa, Batchelor, Tracy T., Longtine, Janina A., Ligon, Keith L., Weaver, Susan, Laforme, Andrea, Ramakrishna, Naren, Black, Peter McL., Drappatz, Jan, Ciampa, Abigail, Folkman, Judah, Kieran, Mark, Wen, Patrick Y.
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2008
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563052/
https://ncbi.nlm.nih.gov/pubmed/18403492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados